Search research articles
Contact Us
Filters
Showing results (221-230 of 266) with videos related to
Page
of 27
Sort By:
Anticancer Research
|
July 1, 1994
Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells
A Sood, B F Spielvogel, W J Powell, et al.
Metal-Based Drugs
|
January 1, 1996
Transepithelial Transport and Metabolism of Boronated Dipeptides Across Caco-2 and HCT-8 Cell Monolayers
A L Elkins, J G Eley, M C Miller Iii, et al.
Metal-Based Drugs
|
January 1, 1996
The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism
M E Murphy, A L Elkins, R P Shrewsbury, et al.
Pharmacotherapy
|
August 6, 1998
Effect of plasma TNF-alpha on filgrastim-stimulated hematopoiesis in mice and humans
W P Petros, J Rabinowitz, J P Gibbs, et al.
Anticancer Research
|
July 1, 1992
Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells
I H Hall, E S Hall, L K Chi, et al.
Metal-Based Drugs
|
January 1, 1995
The anti-inflammatory activity of boron derivatives in rodents
I H Hall, B S Burnham, S Y Chen, et al.
Metal-Based Drugs
|
January 1, 1994
The hypolipidemic activity of metal complexes of amine carboxyboranes in rodents
I H Hall, B F Spielvogel, A Sood, et al.
Archiv Der Pharmazie
|
May 31, 2001
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones
I H Hall, B J Barnes, E S Ward, et al.
Die Pharmazie
|
May 8, 2000
Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells
Y K Yan, S E Cho, K A Shaffer, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1979
Antitumor agents: structure--activity relationships in tenulin series
T G Waddell, A M Austin, J W Cochran, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 266) with videos related to
Sort By:
Page
of 27
Anticancer Research
|
July 1, 1994
Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells
A Sood, B F Spielvogel, W J Powell, et al.
Metal-Based Drugs
|
January 1, 1996
Transepithelial Transport and Metabolism of Boronated Dipeptides Across Caco-2 and HCT-8 Cell Monolayers
A L Elkins, J G Eley, M C Miller Iii, et al.
Metal-Based Drugs
|
January 1, 1996
The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism
M E Murphy, A L Elkins, R P Shrewsbury, et al.
Pharmacotherapy
|
August 6, 1998
Effect of plasma TNF-alpha on filgrastim-stimulated hematopoiesis in mice and humans
W P Petros, J Rabinowitz, J P Gibbs, et al.
Anticancer Research
|
July 1, 1992
Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells
I H Hall, E S Hall, L K Chi, et al.
Metal-Based Drugs
|
January 1, 1995
The anti-inflammatory activity of boron derivatives in rodents
I H Hall, B S Burnham, S Y Chen, et al.
Metal-Based Drugs
|
January 1, 1994
The hypolipidemic activity of metal complexes of amine carboxyboranes in rodents
I H Hall, B F Spielvogel, A Sood, et al.
Archiv Der Pharmazie
|
May 31, 2001
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones
I H Hall, B J Barnes, E S Ward, et al.
Die Pharmazie
|
May 8, 2000
Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells
Y K Yan, S E Cho, K A Shaffer, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1979
Antitumor agents: structure--activity relationships in tenulin series
T G Waddell, A M Austin, J W Cochran, et al.
Page
of 27